TERESA HURST: Open Payments
NPI 1184685927 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 78 payments from 19 companies in 2025. Trend: 2023 $782 · 2024 $882 · 2025 $1,504
Food & beverage: $1,323Education: $181
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 24 | $302 |
| Teva Pharmaceuticals USA, Inc. | 9 | $240 |
| Axsome Therapeutics, Inc. | 7 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Neurocrine BioSciences, Inc. | 4 | $89 |
| ABBVIE INC. | 5 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Corium, LLC | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Lundbeck LLC | 4 | $65 |
Products named: ARISTADA, LYBALVI, CAPLYTA, INGREZZA, VRAYLAR, REXULTI, FANAPT, Auvelity.
Industry payments across NC — which companies pay providers there.
